These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 12021117

  • 1. Relation between course of disease in type 1 diabetes and islet cell antibodies.
    Zamaklar M, Jotic A, Lalic N, Lalic K, Rajkovic N, Milicic T.
    Ann N Y Acad Sci; 2002 Apr; 958():251-3. PubMed ID: 12021117
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Gorus FK, Belgian Diabetes Registry.
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
    Karjalainen JK.
    Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
    [Abstract] [Full Text] [Related]

  • 6. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inouye K, Kono M.
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M, Gomis R, Ercilla G, Casamitjana R, Bottazzo GF, Pujol-Borrell R.
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A, Szelachowska M, Kinalska I.
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [Abstract] [Full Text] [Related]

  • 13. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
    Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, Bingley PJ.
    Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C, Kolmodin M, Ivarsson SA, Carlsson A, Forsander G, Lindblad B, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Ortqvist E, Lernmark A, Elding Larsson H, Törn C, Better Diabetes Diagnosis Study Group.
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for the course of beta cell function in autoimmune diabetes.
    Törn C, Landin-Olsson M, Lernmark A, Palmer JP, Arnqvist HJ, Blohmé G, Lithner F, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L, Ostman J.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4619-23. PubMed ID: 11134117
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Saï P.
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [Abstract] [Full Text] [Related]

  • 20. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T, Mølvig J, Andersen HU, Helqvist S, Spinas GA, Munck M.
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.